Jagsonpal Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

208.70

236.71

226.10

187.95

158.57

Operating profit

23.07

34.15

25.79

19.08

8.53

Interest

0.81

0.41

0.29

0.51

0.51

Gross profit

31.53

39.47

28.85

22.96

10.54

EPS (Rs)

8.50

10.20

7.48

6.52

3.00

Other income

9.28

5.73

3.34

4.39

2.53

Stock adjustment

3.90

4.30

5.61

5.28

1.25

Raw material

22.10

31.21

40.42

38.63

36.79

Power and fuel

-

-

-

-

-

Employee expenses

48.49

56.41

57.68

53.98

50.37

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

111.15

110.63

96.60

70.97

61.63

Provisions made

-

-

-

-

-

Depreciation

1.66

1.21

1.53

1.09

1.13

Taxation

7.41

8.09

7.73

4.81

1.54

Net profit / loss

22.46

26.72

19.59

17.06

7.87

Extra ordinary item

-

-3.46

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.22

13.10

13.10

13.09

13.10

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.05

14.43

11.41

10.15

5.38

GPM (%)

14.47

16.28

12.57

11.94

6.55

NPM (%)

10.31

11.02

8.54

8.87

4.89